NASDAQ:CRDF

Cardiff Oncology Stock Forecast

etoro logo Buy CRDF
*Your capital is at risk
$1.40
-0.110 (-7.28%)
At Close: Jun 03, 2026
AI Analysis AI Analysis of CRDF AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add CRDF to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Volatile ride for Cardiff Oncology Inc. stock price on Wednesday moving between $1.36 and $1.55
(Updated on Jun 03, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jun 01, 2026 Loss -5.41%

The Cardiff Oncology Inc. stock price fell by -7.28% on the last day (Wednesday, 3rd Jun 2026) from $1.51 to $1.40. During the last trading day the stock fluctuated 13.97% from a day low at $1.36 to a day high of $1.55. The price has been going up and down for this period, and there has been a -20.45% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -195 thousand shares and in total, 2 million shares were bought and sold for approximately $3.48 million.

The stock has broken the very wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($1.42) are considered to be a "second chance" to get out. According to the fan-theory $0.92 will represent the new bottom line of the next trend, but it is far too early to say this for certain.

CRDF Signals & Forecast

There are few to no technical positive signals at the moment. The Cardiff Oncology Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.70 and $1.70. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, May 26, 2026, and so far it has fallen -27.84%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Cardiff Oncology Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.190 between high and low, or 13.97%. For the last week, the stock has had daily average volatility of 12.04%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CRDF) For The Upcoming Trading Day Of Thursday 4th

For the upcoming trading day on Thursday, 4th we expect Cardiff Oncology Inc. to open at $1.44, and during the day (based on 14 day Average True Range), to move between $1.33 and $1.47, which gives a possible trading interval of +/-$0.147 (+/-11.07%) up or down from last closing price. If Cardiff Oncology Inc. takes out the full calculated possible swing range there will be an estimated 11.07% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $1.48, some $0.0800 (5.71%) from the current price of $1.40, our system finds the risk reward not very attractive.

Is Cardiff Oncology Inc. stock A Buy?

Cardiff Oncology Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.125 Strong Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 4, 2026 - $1.44 ( 2.62%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CRDF Performance

Trading levels for CRDF

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.63 16.19%
R2 1.55 11.01%
R1 1.51 7.80%
Price 1.40
S1 1.36 -2.57%
S2 1.32 -5.77%
S3 1.25 -10.95%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.67 19.29%
R2 1.51 7.86%
R1 1.48 5.71%
Price 1.40
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Cardiff Oncology Inc. Stock and on which exchange is it traded?
The symbol for Cardiff Oncology Inc. is CRDF and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Cardiff Oncology Inc. Stock?
Cardiff Oncology Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

How to buy Cardiff Oncology Inc. Stock?
Cardiff Oncology Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cardiff Oncology Inc. Stock.

What's the current price of Cardiff Oncology Inc. Stock?
As of the end of day on the Jun 03, 2026, the price of an Cardiff Oncology Inc. (CRDF) share was $1.40.

What is the 52-week high and low for Cardiff Oncology Inc. Stock?
The 52-week high for Cardiff Oncology Inc. Stock is $4.56 and the 52-week low is $1.36.

What is the market capitalization of Cardiff Oncology Inc. Stock?
As of the Jun 03, 2026, the market capitalization of Cardiff Oncology Inc. is 95.718M.

When is the next earnings date for Cardiff Oncology Inc.?
The upcoming earnings date for Cardiff Oncology Inc. is Aug 04, 2026.
Click to get the best stock tips daily for free!
ABOUT CARDIFF ONCOLOGY INC.
Cardiff Oncology
Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; metastatic colorectal cancer that is in clinical trials; and TROV-054 is a Phase 1b/2 for FOLFIRI and bevac...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE